Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk of developing ...

Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk for developing ...

Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...

Johnson & Johnson announced today first results from the Phase 3, randomized, double-blind, placebo-controlled AMPLITUDE study evaluating the combination of niraparib and abiraterone acetate plus ...

Panelists discuss the primary access challenges in chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) treatment, including financial barriers and health care system limitations, and how ...

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

Radionuclide therapy with the radioactive element terbium could effectively combat lymphoma. This is demonstrated by ...

Amgen AMGN announced encouraging new data from its interim analysis of the global late-stage study evaluating Imdelltra ...

A Phase 3 study assessed the second-line use of sintilimab combined with ICE vs placebo combined with ICE in managing patients with classical Hodgkin Lymphoma.